Immunotherapy News and Research

Latest Immunotherapy News and Research

Cancer treatments may impair heart function or cause long-term cardiac damage

While cancer treatments such as chemotherapy and radiation are critical to treating cancers, research shows that some of these treatments may impair heart function or cause long-term heart damage.

30 Jan 2023

Scientists Develop a Cancer Vaccine to Simultaneously Kill and Prevent Brain Cancer

Dual-action cell therapy engineered to eliminate established tumors and train the immune system to eradicate primary tumor and prevent cancer’s recurrence.

30 Jan 2023

International guidelines to help prevent and treat heart complications in pediatric oncology patients

The world's first international clinical guidelines to help prevent and treat heart complications in children undergoing cancer treatment have been created.

29 Jan 2023

Researchers identify an unexpected driver of cancer immunotherapy resistance

A research team from the LKS Faculty of Medicine, the University of Hong Kong (HKUMed) has identified an unexpected driver of cancer immunotherapy resistance: the harmful effect of chronic Type I Interferon signaling on tumor-killing CD8+ T cells.

27 Jan 2023

Pancreatic cancer study reveals the cause of tumor cell resistance to immunotherapy

A new study that analyzed the tumor microenvironment of pancreatic cancer revealed the cause of tumor cell resistance to immunotherapy and resulted in new treatment strategies.

26 Jan 2023

Combination of targeted therapies with immunotherapy addresses treatment resistance in pancreatic cancer

A team of investigators at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine has shown for the first time that a combination of targeted therapies with immunotherapy addresses one of the major reasons pancreatic cancer is so notoriously treatment resistant.

26 Jan 2023

Persistent tumor mutation burden linked with therapeutic response to immunotherapy

Cancer experts have tried, sometimes unsuccessfully, to use the total number of mutations in a tumor, called the tumor mutation burden (TMB), to predict a patient's response to immunotherapy.

26 Jan 2023

UK oncologists and cardiologists collaborate to prevent chemo-induced cardiomyopathy in cancer patients

Ever since she was 12 years old, Barbie Johnson has been a Kentucky girl at heart. Raised in the bluegrass, Barbie has worked at UK HealthCare for 18 years, first in gynecologic oncology and now in surgery scheduling.

26 Jan 2023

Scientists reveal how genetic changes lead to differences in the size of cancer cells

Cancer cells can shrink or super-size themselves to survive drug treatment or other challenges within their environment, researchers have discovered.

25 Jan 2023

Dietary plant sugar promotes antitumor immunity and enhances the efficacy of immunotherapy

Immunotherapies have improved outcomes of many patients with cancer, including melanoma. But these therapies work for only a subset of patients.

23 Jan 2023

CHLA launches first clinical trial for Down syndrome regression disorder with $5.3 million NIH grant

Children's Hospital Los Angeles has launched the first clinical trial for Down syndrome regression disorder (DSRD), a rare and debilitating condition that affects adolescents and young adults with Down syndrome.

23 Jan 2023

Study reviews mechanistic data on new methods of allergy prevention and treatment

In a recent article published in Science Translational Medicine, researchers reviewed the cause and the underlying pathophysiology of allergic diseases.

23 Jan 2023

Wistar scientists receive $397,663 to explore the ability of natural killer cells to kill HIV-infected cells

amfAR, The Foundation for AIDS Research, has awarded Luis J. Montaner, D.V.M., D.Phil., in collaboration with Mohamed Abdel-Mohsen, Ph.D., a Target Grant for $397,663 over two years. Montaner, who leads The Wistar Institute's HIV Research Program, is studying the ability of a type of immune cell known as natural killer (NK) cells to kill HIV-infected cells.

19 Jan 2023

Immunotherapy News and Research

Latest Immunotherapy News and Research

Cancer treatments may impair heart function or cause long-term cardiac damage

Scientists Develop a Cancer Vaccine to Simultaneously Kill and Prevent Brain Cancer

International guidelines to help prevent and treat heart complications in pediatric oncology patients

Researchers identify an unexpected driver of cancer immunotherapy resistance

Pancreatic cancer study reveals the cause of tumor cell resistance to immunotherapy

Combination of targeted therapies with immunotherapy addresses treatment resistance in pancreatic cancer

Persistent tumor mutation burden linked with therapeutic response to immunotherapy

UK oncologists and cardiologists collaborate to prevent chemo-induced cardiomyopathy in cancer patients

Scientists reveal how genetic changes lead to differences in the size of cancer cells

Dietary plant sugar promotes antitumor immunity and enhances the efficacy of immunotherapy

CHLA launches first clinical trial for Down syndrome regression disorder with $5.3 million NIH grant

Study reviews mechanistic data on new methods of allergy prevention and treatment

Wistar scientists receive $397,663 to explore the ability of natural killer cells to kill HIV-infected cells

Researchers create large-scale 2D and 3D spatial maps of colorectal cancer

Protein heat shock transcription factor 1 may be a viable therapeutic target for hepatoblastoma

Researchers develop innovative STAb therapy for a type of leukemia

New drug combination may offer better prognosis for children diagnosed with deadly brain cancer

New cooling strategy could prevent the growth of glioblastoma

Silencing the immune evasion gene enhances cancer cells' susceptibility to immunotherapy

Experts propose solutions to address racial disparities affecting people with allergic conditions

eBook: Cell-based technologies in drug discovery and Immunotherapy eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Immunotherapy News and Research

Latest Immunotherapy News and Research

eBook: Cell-based technologies in drug discovery and Immunotherapy eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in